| Product Name |
Fluticasone USP Related Compound B / Fluticasone Trioxo Impurity |
| Product Category | Impurities, Intermediates |
| Sub-Category | Pharmaceutical Standards, Fine Chemicals |
| CAS No | 219719-95-6 |
| Catalog Number | GS.37.FLT.52 |
| Chemical Name/Synonyms | (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-11-hydroxy-10,13,16-trimethyl-7,8,9,10,11,12,13,14,15,16-decahydrospiro[cyclopenta[a]phenanthrene-17,5'-[1,3]oxathiolane]-2',3,4'(6H)-trione; 6α,9-Difluoro-11β-hydroxy-16α-methyl-2′,3,4′-trioxo-17α-spiro[androsta-1,4-diene-17,5′-(1,3)oxathiolane]; Fluticasone Propionate Related Compound B (USP); |
| Molecular Weight | 438.48 |
| Molecular Formula | C22H24F2O5S |
| Purity | NLT 95 % |
| Applications | Fluticasone Trioxo Impurity is an impurity of Fluticasone Propionate which is used to treat asthma and chronic obstructive pulmonary disease (COPD). |
| Inventory Status | customized |